Page last updated: 2024-12-06

1,8-diaminonaphthalene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,8-Diaminonaphthalene (DAN) is an organic compound with the formula C10H10N2. It is a white solid that is soluble in organic solvents. DAN is a versatile building block for the synthesis of a variety of organic compounds, including polymers, dyes, and pharmaceuticals. Its synthesis is typically achieved through the reduction of 1,8-dinitronaphthalene. DAN exhibits fluorescence properties and is used in optical applications. It is also used as a reagent in organic synthesis and as a precursor to various pharmaceuticals. The study of DAN focuses on its diverse applications in chemistry, material science, and medicine. Its unique structural features contribute to its potential use in various fields.'

1,8-diaminonaphthalene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68067
CHEMBL ID595537
SCHEMBL ID65699
MeSH IDM0496232

Synonyms (46)

Synonym
BIDD:GT0112
nsc-6081
1,8-naphthylenediamine
1,8-diaminonaphthalene
479-27-6
1,8-naphthalenediamine
naphthalene-1,8-diamine
nsc6081
inchi=1/c10h10n2/c11-8-5-1-3-7-4-2-6-9(12)10(7)8/h1-6h,11-12h
1,8-diaminonaphthalene, 99%
nsc 6081
ai3-03804
einecs 207-529-8
1,8-diaminonaphthalene, for fluorescence, >=98.0% (hplc/nt)
AC-11649
D0102
CHEMBL595537
AKOS000120346
ika7029yh9 ,
ec 207-529-8
unii-ika7029yh9
ccris 8398
A827397
BBL011335
STL146425
FT-0607034
PS-4034
S12373
1,8-naphthalenediamine [mi]
SCHEMBL65699
1,8-naphthalene diamine
1,8-diaminonapthalene
1,8-diamino naphthalene
DTXSID6044432
W-106061
STR04194
CS-W016202
mfcd00004033
1,8-diaminonaphthalene, 97%
1,8-diaminonaphthalene, technical, >=95.0% (hplc)
SY035723
Q3277541
4-diphenylacetoxy-n-methylpiperidinemethiodide
nsc801663
nsc-801663
EN300-20681
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID450461Antibacterial activity against Escherichia coli after 24 hrs by twofold serial dilution method2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Interaction of drug based binuclear mixed-ligand complexes with DNA.
AID450458Antibacterial activity against Bacillus subtilis after 24 hrs by twofold serial dilution method2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Interaction of drug based binuclear mixed-ligand complexes with DNA.
AID1059430Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate at 1 mM after 1 hr relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID450459Antibacterial activity against Serratia marcescens after 24 hrs by twofold serial dilution method2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Interaction of drug based binuclear mixed-ligand complexes with DNA.
AID450460Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by twofold serial dilution method2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Interaction of drug based binuclear mixed-ligand complexes with DNA.
AID450457Antibacterial activity against Staphylococcus aureus after 24 hrs by twofold serial dilution method2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Interaction of drug based binuclear mixed-ligand complexes with DNA.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (29.41)29.6817
2010's9 (52.94)24.3611
2020's3 (17.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.01 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]